San Diego's Vital Therapies, Inc. (VTI) Lowers The Bar With 2nd IPO Try

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Vital Therapies lowers the bar in its 2nd try at an initial public offering, aiming to raise up to $68 million this time around.

Bio-artificial liver maker Vital Therapies set the range for its initial public offering at $13 to $15 per share, below the $16 to $18 range it set last year before scuttling its 1st try at a U.S. IPO.

Help employers find you! Check out all the jobs and post your resume.

Back to news